The President of the Government, Pedro Sánchez, has announced that if the authorizations of the European Medicines Agency (EMA) are met, two weeks before the start of the 2021-2022 academic year, the vaccination of ESO and Baccalaureate students could begin .
Health activates vaccination for children under 40 years of age and creates a group to immunize adolescents
This was stated this Saturday in an act of gratitude to the educational community for the work “of honor registration” carried out during the course, which has made Spain one of the “few countries that has kept its schools open to throughout the course “after keeping” 99.8% of the classrooms open.
In addition, Sánchez has assured that in Spain there is “joy of living”, which, in his opinion, “is noticeable in the group of compatriots” because “we are launched in the vaccination, we are going record after record in the doses administered and we are recovering the employment “, which has also been possible thanks to education.
“Spain is going, is launched and has put the direct towards a just and lasting recovery”, according to the President of the Government, who has expressed his satisfaction because next Saturday, June 26, thanks to the health professionals, the educational community and the “Compatriots who have made it possible, we will be able to remove our mask in open spaces.”
Health creates a group to immunize adolescents
Precisely, the Ministry of Health and the autonomous communities approved this Thursday in the Public Health Commission the creation of Three New Age Groups Recipients of COVID-19 Vaccines, one of them for people between 12 and 19 years old. These may begin to be vaccinated “overlapping the uptake of different groups, maintaining the descending age order.” That is, in parallel to those over 40, who are currently being vaccinated, and without having finished with them. The organization and summons, as usual, is in the hands of the autonomous communities.
The Public Health Commission does not specify which vaccines to inoculate people 12 to 39 years of age. From 12 to 18 years only Pfizer / BioNTech is approved, from 18 to 39 you can use that, Moderna, and Janssen / Johnson & Johnson. It was in debate whether the latter would be given to those under 40, due to its link to a few cases of thrombi. But according to the rules so far, the only one not usable for the younger groups, because it is banned to those under 60 for reasons of prevention also of a few cases of thrombi, is AstraZeneca / Oxford.
The moral dilemma of vaccinating minors or donating doses
Many voices call to rethink this immunization of minors, when treating, those who do not have risk conditions, of citizens who are not in danger of suffering serious COVID-19. It would be better, these experts point out, before that, donate doses to countries that have not covered their elderly and vulnerable, something that Spain has already achieved.
Short-term vaccination of children and adolescents is a privilege of Europe, North America and part of Asia. In Latin America, according to Reuters, only Chile, the most advanced country in the region, is considering it: 44% of its population has a complete regimen, especially with one of the Chinese vaccines (Sinovac). In Africa, the most advanced is Morocco, with 16% having a complete pattern. The rest, including South Africa, are below 3%.
In fact, COVAX is a UN donation platform that depends on the member states, and the mechanism by which many impoverished countries are receiving a good part of the doses. The WHO, a leg of the UN, has encouraged to promote it: they warn that it is unethical to start vaccinating the population with less risk when they are old and healthy in Africa, Asia and Latin America without immunizing. The objective of COVAX is to reach at least 20% of the countries it covers before the end of 2021. That of the EU, the United Kingdom or the United States, group immunity.